One Course Versus Two Courses of Antithymocyte Globulin for the Treatment of Severe Aplastic Anemia in Children

Y. H. Matloub(University of Toledo Medical Center), Norma K.C. Ramsay(University of Minnesota), H. James Nickerson(University of Toledo Medical Center), Marion A. Koerper, Stacy Month(University of Toledo Medical Center), C. L. Moertel(University of Toledo Medical Center), Carl S. Smith(University of Toledo Medical Center), Sadik Khuder(University of Toledo Medical Center), P. Monteleone(University of Toledo Medical Center), W. Anthony Smithson(University of Toledo Medical Center), Joanne M. Hilden(Children's Hospital Colorado), Bruce Bostrom(Minnesota West Community & Technical College), Maura O’Leary, Teresa Silberman(University of Toledo Medical Center)
˜The œAmerican journal of pediatric hematology/oncology
March 1, 1997
10.1097/00043426-199703000-00003
Cited by 14

Related Papers

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study
|Blood|2007|536
A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study
|Blood|2002|496
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
|Blood|2003|361
Comparison of Autologous and Allogeneic Bone Marrow Transplantation for Treatment of High-Risk Refractory Acute Lymphoblastic Leukemia
|New England Journal of Medicine|1987|334
Juvenile xanthogranuloma: Forms of systemic disease and their clinical implications
|The Journal of Pediatrics|1996|294